We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
(-25%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-30.05%
Top 10 Holdings %
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$2.36M |
| 2 |
Collegium Pharmaceutical
COLL
|
+$2.32M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$2.29M |
| 4 |
HSII
Heidrick & Struggles
HSII
|
+$2.25M |
| 5 |
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
|
+$2.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emergent Biosolutions
EBS
|
+$5.99M |
| 2 |
Commercial Metals
CMC
|
+$5.95M |
| 3 |
Benchmark Electronics
BHE
|
+$5.84M |
| 4 |
Upbound Group
UPBD
|
+$5.71M |
| 5 |
FreightCar America
RAIL
|
+$5.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.04% |
| 2 | Industrials | 15.17% |
| 3 | Technology | 12.86% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Financials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZGNX
426
DELISTED
Zogenix, Inc.
ZGNX
| $531K | 0.08% |
57,442
-270,041
| -82% | -$2.7M |
|
|
BRSS
427
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $525K | 0.08% |
21,028
-114,227
| -84% | -$2.51M |
|
428
Shenandoah Telecom
SHEN
$637M
| $523K | 0.08% |
+19,546
| New | +$449K |
|
429
Adams Diversified Equity Fund
ADX
$3.11B
| $521K | 0.08% |
+41,210
| New | +$495K |
|
430
Provident Financial Services
PFS
$3.11B
| $516K | 0.07% |
+25,558
| New | +$486K |
|
431
Enanta Pharmaceuticals
ENTA
$370M
| $514K | 0.07% |
+17,487
| New | +$487K |
|
432
Ribbon Communications
RBBN
$359M
| $511K | 0.07% |
67,908
-167,787
| -71% | -$1.12M |
|
|
FARM
433
DELISTED
Farmer Brothers
FARM
| $510K | 0.07% |
18,305
-5,456
| -23% | -$146K |
|
|
NAVG
434
DELISTED
Navigators Group Inc
NAVG
| $508K | 0.07% |
+12,106
| New | +$504K |
|
435
PENN Entertainment
PENN
$2.83B
| $507K | 0.07% |
30,372
-112,214
| -79% | -$1.61M |
|
436
TTM Technologies
TTMI
$12.8B
| $506K | 0.07% |
+76,105
| New | +$469K |
|
|
FPI
437
Farmland Partners
FPI
$420M
| $505K | 0.07% |
+47,091
| New | +$500K |
|
438
NanoViricides
NNVC
$35.4M
| $505K | 0.07% |
+11,525
| New | +$447K |
|
|
SAGE
439
DELISTED
Sage Therapeutics
SAGE
| $505K | 0.07% |
15,755
-13,143
| -45% | -$463K |
|
|
GTY
440
Getty Realty Corp
GTY
$2.12B
| $503K | 0.07% |
25,367
-26,479
| -51% | -$477K |
|
441
Mitek Systems
MITK
$768M
| $503K | 0.07% |
76,913
+55,416
| +258% | +$284K |
|
442
IES Holdings
IESC
$12B
| $502K | 0.07% |
+34,207
| New | +$420K |
|
443
Oxford Industries
OXM
$602M
| $502K | 0.07% |
7,471
-79,623
| -91% | -$5.42M |
|
|
USCR
444
DELISTED
U S Concrete, Inc.
USCR
| $502K | 0.07% |
+8,431
| New | +$429K |
|
|
AAIC
445
DELISTED
Arlington Asset Investment Corp.
AAIC
| $499K | 0.07% |
+39,834
| New | +$481K |
|
446
Ingles Markets
IMKTA
$1.67B
| $497K | 0.07% |
13,264
-18,001
| -58% | -$644K |
|
447
Rush Enterprises Class A
RUSHA
$5.98B
| $496K | 0.07% |
+61,205
| New | +$493K |
|
|
PTLA
448
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $494K | 0.07% |
+24,237
| New | +$769K |
|
449
HUB Group
HUBG
$2.93B
| $490K | 0.07% |
24,034
-93,206
| -80% | -$1.61M |
|
|
FMI
450
DELISTED
Foundation Medicine, Inc.
FMI
| $489K | 0.07% |
+26,918
| New | +$434K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q1 2016 Portfolio in Review
As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.
Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.
- TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
- TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
- TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
- TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
- TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
- TFS Capital opened 502 new positions and closed 257 in Q1 2016.
- TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.
Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.